105 related articles for article (PubMed ID: 5091785)
1. [Mesothelioma of the peritoneum].
Jacyna-Onyszkiewicz T; Panecka A
Pol Przegl Chir; 1971 May; 43(5):737-40. PubMed ID: 5091785
[No Abstract] [Full Text] [Related]
2. Continued uncertainty regarding hyperthermic intraperitoneal chemotherapy in malignant peritoneal mesothelioma.
Markman M
J Clin Oncol; 2010 Aug; 28(24):e418; author reply e419. PubMed ID: 20566999
[No Abstract] [Full Text] [Related]
3. Circulating CA125 and diffuse malignant peritoneal mesothelioma.
Baratti D; Kusamura S; Deraco M
Eur J Surg Oncol; 2009 Nov; 35(11):1198-9. PubMed ID: 19423265
[No Abstract] [Full Text] [Related]
4. [Short-term intraperitoneal infusion of cisplatin and OK-432 for a case of malignant mesothelioma of the peritoneum].
Kuwabara K; Ishida H; Ohsawa T; Nakata H; Murata N; Hashimoto D; Adachi A; Itoyama S
Gan To Kagaku Ryoho; 2002 Nov; 29(12):2333-5. PubMed ID: 12484067
[TBL] [Abstract][Full Text] [Related]
5. An instrument to provide containment of intraoperative intraperitoneal chemotherapy with optimized distribution.
Sugarbaker PH
J Surg Oncol; 2005 Nov; 92(2):142-6. PubMed ID: 16231365
[No Abstract] [Full Text] [Related]
6. Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: the Australian experience.
Chua TC; Yan TD; Morris DL
J Surg Oncol; 2009 Feb; 99(2):109-13. PubMed ID: 19016259
[TBL] [Abstract][Full Text] [Related]
7. Cytoreductive surgery (cs) and hyperthermic intraperitoneal chemotherapy (hipec) in treatment of peritoneal surface malignances: report of a phase II clinical study.
Asero S; Caruso M; Vallone N; Luciani AG; Lombardo V; Terranova G; Ettore G; Giannone G
In Vivo; 2009; 23(4):645-7. PubMed ID: 19567402
[TBL] [Abstract][Full Text] [Related]
8. Cytoreductive surgery and intraperitoneal chemotherapy for peritoneal mesothelioma.
Yano H; Moran BJ; Cecil TD; Murphy EM
Eur J Surg Oncol; 2009 Sep; 35(9):980-5. PubMed ID: 18977109
[TBL] [Abstract][Full Text] [Related]
9. Peritoneum as the first-line of defense in carcinomatosis.
Sugarbaker PH
J Surg Oncol; 2007 Feb; 95(2):93-6. PubMed ID: 17262739
[No Abstract] [Full Text] [Related]
10. [Malignant mesothelioma of the peritoneum. Case report].
Richter B; Richter P; Buchholz K
Zentralbl Gynakol; 1983; 105(9):598-601. PubMed ID: 6880476
[TBL] [Abstract][Full Text] [Related]
11. [Updated treatment of peritoneal carcinomas: a review].
Deraco M; Laterza B; Kusamura S; Baratti D
Minerva Chir; 2007 Dec; 62(6):459-76. PubMed ID: 18091656
[TBL] [Abstract][Full Text] [Related]
12. Morbidity and mortality assessment of cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma--a prospective study of 70 consecutive cases.
Yan TD; Edwards G; Alderman R; Marquardt CE; Sugarbaker PH
Ann Surg Oncol; 2007 Feb; 14(2):515-25. PubMed ID: 17031722
[TBL] [Abstract][Full Text] [Related]
13. [Sudden increase in abdominal circumference in a young man].
Slawik HR; Wienbeck M; Wagner T; Lindemann F; Hassel J
Internist (Berl); 1991 Aug; 32(8):492-4. PubMed ID: 1938271
[No Abstract] [Full Text] [Related]
14. Peritoneal mesothelioma treated by induction chemotherapy, cytoreductive surgery, and intraperitoneal hyperthermic perfusion.
Deraco M; Casali P; Inglese MG; Baratti D; Pennacchioli E; Bertulli R; Kusamura S
J Surg Oncol; 2003 Jul; 83(3):147-53. PubMed ID: 12827682
[TBL] [Abstract][Full Text] [Related]
15. [A case of ascities decrease in malignant peritoneal mesothelioma by weekly intra-peritoneal administration of cisplatin and paclitaxel].
Ami K; Nagahama T; Andou M; Nawa K; Ganno H; Ohbu M; Kimu K; Ito T; Yamauchi A; Ichikawa S; Kobo T; Takaba E
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1709-11. PubMed ID: 16315916
[TBL] [Abstract][Full Text] [Related]
16. A pharmacologic analysis of intraoperative intracavitary cancer chemotherapy with doxorubicin.
Van der Speeten K; Stuart OA; Mahteme H; Sugarbaker PH
Cancer Chemother Pharmacol; 2009 Apr; 63(5):799-805. PubMed ID: 18654746
[TBL] [Abstract][Full Text] [Related]
17. Consensus statement on peritoneal mesothelioma.
Deraco M; Bartlett D; Kusamura S; Baratti D
J Surg Oncol; 2008 Sep; 98(4):268-72. PubMed ID: 18726890
[TBL] [Abstract][Full Text] [Related]
18. [Diagnosis and treatment of 41 patients with malignant peritoneal mesothelioma].
Zhang ZG; Hao XS
Zhonghua Zhong Liu Za Zhi; 2004 Oct; 26(10):631-3. PubMed ID: 15634530
[TBL] [Abstract][Full Text] [Related]
19. Continuous hyperthermic peritoneal perfusion with cisplatin for the treatment of peritoneal mesothelioma.
Ma GY; Bartlett DL; Reed E; Figg WD; Lush RM; Lee KB; Libutti SK; Alexander HR
Cancer J Sci Am; 1997; 3(3):174-9. PubMed ID: 9161783
[TBL] [Abstract][Full Text] [Related]
20. Building on a consensus.
Sugarbaker PH
J Surg Oncol; 2008 Sep; 98(4):215-6. PubMed ID: 18726906
[No Abstract] [Full Text] [Related]
[Next] [New Search]
